ArticleBriefings in bioinformatics2026
Uncovering species- and drug-class-specific antimicrobial resistance mechanisms from large-scale whole-genome sequencing data using discordance analysis and machine learning.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Whole-genome sequencing has become the standard molecular platform for antimicrobial resistance surveillance, yet existing computational approaches-gene catalogs that ignore expression, k-mer machine learning (ML) that lacks mechanistic interpretability, and Single Nucleotide Polymorphism-based methods that capture only one resistance mechanism-suffer from systematic genotype-phenotype discordance whose molecular causes remain unquantified. We present a 16-step genomic annotation protocol that integrates promoter strength, ribosome binding site efficiency, codon adaptation, mobile element context, and chromosomal point mutations, and benchmark four ML classifiers across 20 296 bacterial genomes from five World Health Organization priority species with matched susceptibility phenotypes. Variant-specific discordance analysis revealed three categories of genotype-phenotype mismatch: antibiotics predictable by gene presence alone (tetracyclines, sulfonamides); those requiring expression context to distinguish functional from silent genes (β-lactams, aminoglycosides); and those dependent on chromosomal mutations invisible to gene catalogs (quinolones). Silent resistance genes showed 30%-85% lower predicted translation initiation rates, 4%-14% lower gene coverage, and weaker promoter activity than functional copies. Among the four classifiers evaluated, Random Forest achieved the highest performance. Expression features improved its F1 by 0.07-0.11 for β-lactams and aminoglycosides but were irrelevant for quinolones, where point mutations were essential. Mobility and regulation features were dispensable. The full model achieved mean F1 of 0.804-0.932 across species; SHapley Additive exPlanations analysis confirmed that the dominant predictive feature per drug class directly reflects its known resistance mechanism, and phylogeny-blocked cross-validation confirmed that single-gene predictions generalize across lineages. These findings establish a mechanistic framework for when and why genomic prediction fails, with direct implications for the design of clinical sequencing-based diagnostic tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.